Cancer Gateway

Welcome to BioMed Central's Cancer Gateway, highlighting the latest articles we have published in this field. Content is continually updated, so please bookmark this page and ensure you check it regularly.

Articles

There has been an error retrieving the data. Please try again.

PALB2 mutations in 1.5% familial breast cancers

Carrying a high risk of breast cancer, PALB2 mutations appear in 1.5% of familial breast cancer cases studied in Australasia, supporting inclusion of the gene in breast cancer genetic screens.

Breast Cancer Research 2013, 15:R17
Fascin-1 as a cancer biomarker?

Vathany Kulasingam and Eleftherios Diamandis comment on a meta-analysis reporting that fascin-1 is associated with cancer mortality and metastasis, and discuss why further research is required before this protein can be used as a biomarker.

BMC Medicine 2013, 11:53
Vitamin D and breast cancer risk

Large case-control studies show circulating 25-hydroxyvitamin D levels are not linked to breast cancer risk, adding to evidence suggesting that higher vitamin D levels do not aid in cancer prevention.

Breast Cancer Research 2013, 15:R15
Fascin-1 linked to cancer mortality

Evidence from a systematic review and meta-analysis shows that fascin-1 is associated with risk of metastasis and mortality in several cancer types, suggesting that it could be developed as a clinical biomarker or therapeutic target for cancer.

BMC Medicine 2013, 11:52

AuthorMapper

Authors of BioMed Central cancer-related articles, by location

News and events

Biomarker Research, a new journal encompassing all aspects biomarker investigation, has now launched. Visit the journal website to read the first articles, including a review by co-Editor-in-Chief Delong Liu on the clinical applications of JAK inhibitors, and sign up for article alerts.